2019-2023 North America Infectious Disease Testing Market: USA, Canada, Mexico--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

This new report provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The report provides granular market segmentation analysis and forecasts for over 100 microbiology tests; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the worlds major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes, Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Country Analyses

Canada, Mexico, US

Market Segmentation Analysis

- Sales and market shares of major suppliers of
infectious disease diagnostic products in major countries by test.

- Test and sales forecasts for 100 infectious disease diagnostic
assays by country, individual test and market segment:

- Review of market dynamics, trends,
structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of major diseases,
including their etiology, current diagnostic tests,
vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
testing, including their operating
characteristics, features and selling prices.

Technology Review

- Assessment of emerging diagnostic technologies and their potential
applications for infectious disease testing.

- Companies developing or
marketing infectious disease diagnostic products
by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.

Opportunities and Strategies for Suppliers

- Emerging opportunities for new instrumentation,
reagent systems, IT and other products with significant market
appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Overview of Major Tests,
Technologies and Instrumentation
A. Major Infectious Disease Tests
1. AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Carbapenemase
13. Chagas Disease
14. Chancroid
15. Chlamydia

16. Clostridium Difficile
17. Coronaviruses
18. Coxsackieviruses
19. Creutzfeldt-Jakobs Disease
20. Cryptosporidium Parvum
21. Cyclospora Cayetanensis
22. Cytomegalovirus
23. Ebola Virus
24. E. Coli
25. Echovirus
26. Encephalitis
27. Enteroviruses
28. Epstein-Barr Virus
30. Giardia Lamblia
31. Gonorrhea
32. Granuloma Inguinale
33. Hantavirus
34. Helicobacter Pylori
35. Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,
Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
HBe Ag, ALT/SGPT
36. Herpes Simplex Virus
37. Human Herpes Virus-6 (HHV-6)
38. Influenza Viruses
39. Legionella
40. Lyme Disease
41. Lymphogranuloma Venereum (LGV)
42. Malaria
43. Measles (Rubeola)
44. Meningitis
45. Microsporidium
46. Mononucleosis
47. Mumps
48. Mycoplasma
49. Norovirus
50. Papillomaviruses
51. Parvovirus B19
52. Pneumonia
53. Polyomaviruses
54. Pseudomonas Aeruginosa
55. Rabies
56. Respiratory Syncytial Virus (RSV)
57. Rhinoviruses
58. Rotavirus
59. Rubella
60. Salmonellosis
61. Septicemia
62. Shigellosis

63. Staphylococcus Aureus
64. Streptococci
65. Syphilis
66. Toxoplasmosis
67. Trichomonas Vaginalis
68. Tuberculosis
69. Vibrio
70. West Nile Virus
71. Yersina
B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
VII. Country Analyses: Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares
- Canada
- Mexico
- USA

VIII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

List Of Tables

Canada
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Canada
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Mexico
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Mexico
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
U.S.A. Summary Table
All Infectious Diseases Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Laboratories Performing Infectious Disease
Tests by Market Segment
U.S.A.
Hospital Laboratories Performing Infectious
Disease Tests by Bed Size
U.S.A.
Commercial/Private Laboratories Performing Infectious
Disease Tests by Annual Test Volume
U.S.A.
Physician Office Laboratories Performing Infectious
Disease Tests by Practice Size
U.S.A.
All Market Segments Infectious Disease
Test Volume Forecast
U.S.A.
All Market Segments Infectious Disease
Test Volume by Method
U.S.A.
Hospital Laboratories Infectious Disease
Test Volume Forecast

U.S.A.
Blood Banks Infectious Disease
Test Volume Forecast
U.S.A.
Physician Office Laboratories Infectious Disease
Test Volume Forecast
U.S.A.
Commercial/Private Laboratories Infectious Disease
Test Volume Forecast
U.S.A.
Public Health Laboratories Infectious Disease
Test Volume Forecast
U.S.A.
All Market Segments Infectious Disease
Diagnostics Market Forecast
U.S.A.
Hospital Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
Blood Banks Infectious Disease
Diagnostics Market Forecast
U.S.A.
Physician Office Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
Commercial/Private Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
Public Health Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
HIV or HIV I/HIV II/Combo Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S.A.
HIVAg Test Volume and Diagnostics Sales
Forecast by Market Segment

U.S.A.
Western Blot/Other Confirmatory Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S.A.
Adenovirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Aeromonads Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
BEA Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Blastocystis Hominis Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Campylobacter Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Candida Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Carbapenemase Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Chancroid Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Chlamydia Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Clostridium Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Coronavirus Test Volume and Diagnostics Sales
Forecast by Market Segment

U.S.A.
CoxsackieVirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Cryptosporidium Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Cyclospora Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
CMV Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
E. Coli Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Echovirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Encephalitis Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Enterovirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
EBV Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Giardia Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Gonorrhea Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Granuloma Inguinale Test Volume and Diagnostics
Sales Forecast by Market Segment

U.S.A.
Hantavirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available